73
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Development of a cardiologist delivered service leads to improved outcomes following admission with acute coronary syndromes in a large district general hospital

, , , , , , , & show all
Pages 1-4 | Received 02 Oct 2011, Accepted 04 Nov 2011, Published online: 24 Jan 2012

References

  • J Herlitz, B Karlson, M Sjolin, J Lindqvist. Ten year mortality in subsets of patients with an acute coronary syndrome. Heart 2001;86:391–6.
  • Bertrand ME, Simoons M, Fox K, . Task force on the management of acute coronary syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002;23:1809–40.
  • Damman P, Hirsch A, Windhausen F, Tijssen JG, de Winter RJ, ICTUS investigators. 5-year clinical outcomes in the ICTUS (invasive versus conservative treatment in unstable coronary syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol. 2010;55:858–64.
  • Popma JJ, Suk J. Use of coronary revascularisation in patients with unstable angina and non-ST-segment elevation myocardial infarction. Am J Cardiol. 2001;88(8A):25K 29K.
  • Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, ., Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527–33.
  • De Luca G, Navarese E, Marino P. Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. Eur Heart J. 2009;30: 2705–13.
  • Murphy SA, Cannon CP, Wiviott SD, McCabe CH, Braunwald E. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22) trial. J Am Coll Cardiol. 2009;54:2358–62.
  • Birkhead JS, Weston C, Lowe D. Impact of specialty of admitting physician and type of hospital on care and outcome for myocardial infarction in England and Wales during 2004–2005: observational study. Br Med J. 2006;332:1306–11.
  • Myocardial ischaemia national audit project (MINAP). How the NHS cares for patients with heart attacks. Tenth public report 2011.
  • Myocardial ischaemia national audit project (MINAP). How the NHS manages heart attacks. Seventh public report 2008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.